This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gläsker, S. Articles by Vortmeyer, A. O. Search for Related Content PubMed PubMed Citation Articles by Gläsker, S. Articles by Vortmeyer, A. O.

Effects of VHL Deficiency on Endolymphatic Duct and Sac

¹ Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke; ² Diagnostic Radiology Department, Warren G. Magnuson Clinical Center, NIH, Bethesda, Maryland; and ³ Renal Section, Imperial College of Science Technology and Medicine, Hammersmith Hospital, London, United Kingdom

Requests for reprints: Alexander O. Vortmeyer, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH, 10 Center Drive, Room 5D37, Bethesda, MD 20892. Phone: 301-594-2914; Fax: 301-402-0380; E-mail: vortmeyera{at}ninds.nih.gov.

The von Hippel-Lindau (VHL) disease is caused by VHL germ line mutation. Inactivation of the wild-type copy of the VHL gene leads to up-regulation of hypoxic response and tumor formation within central nervous system (CNS), kidneys, pancreas, adrenal glands, epididymis, broad ligament, and the endolymphatic sac/petrous bone. Endolymphatic sac tumors (ELST) have been proposed to be derived from endolymphatic sac epithelium, but other possible structures of origin have been implicated. To clarify the anatomic and cellular origin of ELSTs, we did a morphologic and molecular pathologic analysis of 16 tumors. In addition, we investigated effects of VHL deficiency on "tumor-free" endolymphatic duct and sac of VHL patients. Several tumors included in this study were <1 cm in size, and their origin could be placed in the intraosseous portion of the endolymphatic duct/sac. Furthermore, by analysis of clinically uninvolved "tumor-free" endolymphatic duct and sac tissues of VHL patients, we discovered a variety of VHL-deficient microscopic abnormalities with morphologic similarities to ELSTs. We conclude that most, if not all, ELSTs arise within the intraosseous portion of the endolymphatic duct/sac, the vestibular aqueduct. In analogy to renal parenchyma and selected topographical sites within the CNS, endolymphatic duct/sac epithelia are preferentially and multifocally targeted in VHL disease. The primary effect of VHL deficiency on human endolymphatic duct/sac epithelium seems to be the generation of multifocal sites of VHL-deficient cell proliferations from which tumorigenesis may or may not occur. Therefore, inactivation of the VHL wild-type allele seems necessary but not sufficient for the formation of tumor.

This article has been cited by other articles:

				J. A. Butman, W. M. Linehan, and R. R. Lonser Neurologic Manifestations of von Hippel-Lindau Disease JAMA, September 17, 2008; 300(11): 1334 - 1342. [Abstract] [Full Text] [PDF]

				I. J. Frew, A. Minola, S. Georgiev, M. Hitz, H. Moch, S. Richard, A. O. Vortmeyer, and W. Krek Combined Vhlh and Pten Mutation Causes Genital Tract Cystadenoma and Squamous Metaplasia Mol. Cell. Biol., July 15, 2008; 28(14): 4536 - 4548. [Abstract] [Full Text] [PDF]

				K.Y. Tay, E. Yu, and E. Kassel Spinal Metastasis from Endolymphatic Sac Tumor AJNR Am. J. Neuroradiol., April 1, 2007; 28(4): 613 - 614. [Abstract] [Full Text] [PDF]